A model for harmonizing flow cytometry in clinical trials.
Journal Article (Journal Article)
Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues.
Full Text
- Published version (via Digital Object Identifier)
- Pubmed Central version
- Open Access Copy from Duke
- Link to Item
Duke Authors
Cited Authors
- Maecker, HT; McCoy, JP; FOCIS Human Immunophenotyping Consortium, ; Amos, M; Elliott, J; Gaigalas, A; Wang, L; Aranda, R; Banchereau, J; Boshoff, C; Braun, J; Korin, Y; Reed, E; Cho, J; Hafler, D; Davis, M; Fathman, CG; Robinson, W; Denny, T; Weinhold, K; Desai, B; Diamond, B; Gregersen, P; Di Meglio, P; Nestle, FO; Peakman, M; Villanova, F; Ferbas, J; Field, E; Kantor, A; Kawabata, T; Komocsar, W; Lotze, M; Nepom, J; Ochs, H; O'Lone, R; Phippard, D; Plevy, S; Rich, S; Roederer, M; Rotrosen, D; Yeh, J-H
Published Date
- November 2010
Published In
Volume / Issue
- 11 / 11
Start / End Page
- 975 - 978
PubMed ID
- 20959798
Pubmed Central ID
- PMC3400260
Electronic International Standard Serial Number (EISSN)
- 1529-2916
Digital Object Identifier (DOI)
- 10.1038/ni1110-975
Language
- eng
Conference Location
- United States